Approximately 25% of patients with thymic carcinoid tumors harbor a MEN1 germline mutation [68] and 8% of MEN1 patients develop thymic neuroendocrine tumors [69]. The gene discussed is MEN1; the disease is thymic neuroendocrine tumor.